FutuRx

General Data

Reg Number
514904440
Additional Funding
0

Description

ReadeRx is developing small molecule inhibitors targeting the RNA binding protein IGF2BP1 as a novel treatment for cancer.

Contact information

Name
Mor Hanan
Email
[email protected]
Phone
0545468236
Website
http://www.futurx.co.il

Classified Technologies

Biomedicine and pharmaceuticals

Winning details

Route name
Winning year

Designated biotechnology incubators
Designated biotechnology incubators
2023
Designated biotechnology incubators
Designated biotechnology incubators
2023
To the full list